Halozyme Therapeutics (HALO) has the following price history information. Looking back at HALO historical stock prices for the last five trading days, on April 12, 2024, HALO opened at $39.00, traded as high as $39.28 and as low as $38.53, and closed at $38.61. Trading volume was a total of 780.30K shares. On April 15, 2024, HALO opened at $38.89, traded as high as $39.27 and as low as $38.48, and closed at $38.72. Trading volume was a total of 843.70K shares. On April 16, 2024, HALO opened at $38.35, traded as high as $38.81 and as low as $38.09, and closed at $38.38. Trading volume was a total of 642.30K shares. On April 17, 2024, HALO opened at $38.69, traded as high as $38.78 and as low as $37.98, and closed at $38.02. Trading volume was a total of 733.90K shares. On April 18, 2024, HALO opened at $37.95, traded as high as $38.41 and as low as $37.73, and closed at $37.81. Trading volume was a total of 792.50K shares.

HALO Historical Stock Prices By Date:

Jan Feb Mar Apr May Jun Jul Aug Sep Oct Nov Dec

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31

1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 20142015201620172018201920202021202220232024

Below, we examine the compound annual growth rate — CAGR for short — of an investment into Halozyme Therapeutics shares, starting with a $10,000 purchase of HALO, and working forward through the historical stock price information to today.

Growth of $10,000.00 Without Dividends Reinvested
Start date:	04/22/2014
End date:	04/18/2024
Start price/share:	$7.83
End price/share:	$37.81
Dividends collected/share:	$0.00
Total return:	382.89%
Average Annual Total Return:	17.06%
Starting investment:	$10,000.00
Ending investment:	$48,294.51
Years:	10.00

HALO Historical Price Range
Date	Open	High	Low	Close	Volume
04/12/2024	$39.00	$39.28	$38.53	$38.61	780.30K
04/15/2024	$38.89	$39.27	$38.48	$38.72	843.70K
04/16/2024	$38.35	$38.81	$38.09	$38.38	642.30K
04/17/2024	$38.69	$38.78	$37.98	$38.02	733.90K
04/18/2024	$37.95	$38.41	$37.73	$37.81	792.50K

About Halozyme Therapeutics

Halozyme Therapeutics is a biopharma technology platform company that provides solutions to improve patient experience and outcomes. Co.'s approved product and its collaborators' approved products and product candidates are based on rHuPH20, its patented recombinant human hyaluronidase enzyme. Co. refers to the application of rHuPH20 to facilitate the delivery of other drugs or fluids as its ENHANZE® drug delivery technology (ENHANZE). Co. licenses the ENHANZE technology to form collaborations with biopharmaceutical companies that develop or market drugs requiring or benefiting from injection via the subcutaneous route of administration.

HALO Historical Closing Prices
Date	Close
04/12/2024	$38.61
04/15/2024	$38.72
04/16/2024	$38.38
04/17/2024	$38.02
04/18/2024	$37.81

Healthcare Historical Prices

HALO is categorized under the Healthcare sector; below are some other companies in the same sector: HART Historical Stock Prices HBIO Historical Stock Prices HCA Historical Stock Prices HEB Historical Stock Prices HGR Historical Stock Prices HH Historical Stock Prices HITK Historical Stock Prices HLS Historical Stock Prices HMA Historical Stock Prices HMSY Historical Stock Prices Also explore: HALO shares outstanding history Free HALO Email Alerts: Get Dividend Alerts Get SEC Filing Alerts

HALO Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.